Van Herk, which is Crucell's second-biggest shareholder with a 10.02 percent stake, on Thursday said Crucell's stand-alone value should be 27.50 euros per share and it would ask Crucell management to convene a shareholder meeting to discuss the bid.
€27.50 is 11% higher than JNJ’s offer of €24.75.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”